Serious liver disease induced by infliximab (original) (raw)

Internal and emergency …, 2010

A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis

Heikki Makisalo

Journal of Crohn's and Colitis, 2012

View PDFchevron_right

Occurrence of hepatoxicicty and elevated liver enzymes in a Crohnʼs disease patient treated with infliximab

Bjørn Moum

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Infliximab single administration followed by acute liver injury

Enzo Ierardi, Maurizio Nacchiero

Inflammatory Bowel Diseases, 2006

View PDFchevron_right

Infliximab-induced hepatitis: absence of cross-toxicity with etanercept

Gérard Thiéfin, Marie-danièle Diebold

Joint Bone Spine, 2008

View PDFchevron_right

Infliximab‐induced autoimmune hepatitis requiring liver transplantation

Karim Qumosani

Clinical Case Reports

View PDFchevron_right

Onset of Liver Damage after a Single??Administration of Infliximab??in??a Patient with Refractory??Ulcerative Colitis

Enzo Ierardi, Maurizio Nacchiero

Clinical Drug Investigation, 2006

View PDFchevron_right

Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry

Janez Zibert

Rheumatology International, 2012

View PDFchevron_right

Severe hepatic toxicity after administration of infliximab in psoriasis treatment

Ana Maria Singeap

Archive of Clinical Cases, 2014

View PDFchevron_right

Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report

MARLEY RIBEIRO FEITOSA

Journal of medical case reports, 2015

View PDFchevron_right

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases

Guilherme Macedo

World journal of gastroenterology : WJG, 2015

View PDFchevron_right

Clinical connection between rheumatoid arthritis and liver damage

Biljana Radovanovic Dinic

Rheumatology international, 2018

View PDFchevron_right

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

Raquel Portugal

Inflammatory Bowel Diseases, 2008

View PDFchevron_right

Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis

Rossana Scrivo

Joint Bone Spine, 2008

View PDFchevron_right

Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists

Björn Guðbjörnsson

Clinical Gastroenterology and Hepatology, 2015

View PDFchevron_right

CASE REPORT Open Access Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report

MARLEY RIBEIRO FEITOSA

2016

View PDFchevron_right

Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases

Robert Fontana

Clinical Gastroenterology and Hepatology, 2013

View PDFchevron_right

Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab

Wenyi Luo

Journal for ImmunoTherapy of Cancer

View PDFchevron_right

A rare association of rheumatoid arthritis and primary biliary cirrhosis treated with rituximab: a case report

Nadira Kadi, Taoufik Harzy

Journal of Medical Case Reports, 2013

View PDFchevron_right

Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis

HASSAN Riad

Case Reports in Dermatology, 2013

View PDFchevron_right

Complications of Rheumatoid Arthritis and Associated Diseases of the Liver - A Postmortem Clinicopathologic Study of 152 Patients

M. Bély

Archives of Gastroenterology and Hepatology

View PDFchevron_right

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy

Emmanuel Tsochatzis

Scandinavian Journal of Gastroenterology, 2007

View PDFchevron_right

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports

Rifaat Safadi

International Journal of General Medicine, 2011

View PDFchevron_right

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate

Paolo Sfriso

Annals of the Rheumatic Diseases, 2003

View PDFchevron_right

Hepatoprotective Effect of Infliximab, an Anti-TNF-α Agent, on Carbon Tetrachloride-Induced Hepatic Fibrosis

ahmet isik

Inflammation, 2008

View PDFchevron_right

Prevalence and Risk Factors for Drug-Induced Liver Injury Among Patients With Rheumatic Diseases Treated With Biological Therapy: A Single-Center Experience

Tomas Koller

Physiological Research, 2019

View PDFchevron_right

Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab

Owen Epstein

European journal of gastroenterology & hepatology, 2016

View PDFchevron_right

Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review

Fernando Saraiva

Clinical Rheumatology, 2012

View PDFchevron_right

Additional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study

Saeed Akhlaghi

Therapeutics and Clinical Risk Management

View PDFchevron_right

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor

S. Sazliyana, Sakthiswary Rajalingham

Journal of Clinical Medicine Research, 2011

View PDFchevron_right

Use of Anti-Tumor Necrosis Factor Alpha Therapy in Patients with Concurrent Rheumatoid Arthritis and Hepatitis B or Hepatitis C: A Retrospective Analysis of 32 Patients

P. Conigliaro

Drug Development Research, 2014

View PDFchevron_right

Hepatic manifestations of autoimmune rheumatic diseases

A. Jawad

Annals of the Rheumatic Diseases, 2004

View PDFchevron_right

Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation

Amedeo Indriolo

Alimentary Pharmacology & Therapeutics, 2013

View PDFchevron_right

Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn’s disease patient upon infliximab-induced lupus-like syndrome

Simon Hirschmann

Therapeutic Advances in Gastroenterology

View PDFchevron_right

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

Eric Toussirot

Joint Bone Spine, 2012

View PDFchevron_right

Serious liver disease induced by infliximab (original) (raw)

Related papers